Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
filingDate |
1999-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f88bc8f8f23e35a63b8364d764daabc0 |
publicationDate |
2003-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BG-63918-B1 |
titleOfInvention |
QUINOLINE AND CHINASOLINE COMPOUNDS APPLICABLE IN MEDICINE, IN PARTICULAR IN THE TREATMENT OF GOOD QUALITY PROSTATE HYPERPLACE, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION |
abstract |
The compounds and their pharmaceutically acceptable salts have the formula ## STR3 ## wherein R1 represents a C1-4 alkoxy group optionally substituted by one or more fluorine atoms; R2 represents an H or C1-6 alkoxy group optionally substituted by one or more fluorine atoms; R3 represents a 5- or 6-membered heterocyclic ring which may be optionally substituted; R4 represents a 4-, 5-, 6- or 7-membered heterocyclic ring which may optionally be fused to a benzene ring or a 5- or 6-membered heterocyclic ring, with the entire ring system being optionally substituted; X is CH or N and L is absent, or represents a cyclic group of formula N or a chain of formula. |
priorityDate |
1997-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |